AmeriFlex Group’s IDEAYA Biosciences IDYA Stock Holding History

AmeriFlex Group’s Portfolio IDYA Stock Details IDYA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.32K	Buy	+89	New	+$2.72K	﹤0.01%	1138

Other funds holding IDYA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

AmeriFlex Group's IDYA Position: Q2 2026 in Review

AmeriFlex Group opened a new position in IDEAYA Biosciences (IDYA) in Q2 2026: 89 shares worth $3.32K. The stake represents ﹤0.01% of the portfolio and ranks #1138 among its holdings.

282 funds tracked by Wall St. Rank hold IDYA as of Q2 2026.

AmeriFlex Group held 89 shares of IDEAYA Biosciences worth $3.32K as of Q2 2026.
IDEAYA Biosciences was a new AmeriFlex Group position in Q2 2026.
IDEAYA Biosciences made up ﹤0.01% of AmeriFlex Group's portfolio in Q2 2026, its #1138 holding.
282 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q2 2026.

Based on AmeriFlex Group's 13F filing for Q2 2026, filed 14 Aug 2026.